Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Hbv Tdf'

Hbv Tdf published presentations and documents on DocSlides.

HIV…HBV…HCV Triple Elimination

HIV…HBV…HCV Triple Elimination

  • hazel
  • 30 Slides

What will it take to achieve?. HIV and Co-infectio...

1 Clarify Informed Consent of Transmittable Conditions

1 Clarify Informed Consent of Transmittable Conditions

  • callie
  • 19 Slides

Ad Hoc Disease Transmission Advisory Committee (DT...

Overview of Gastroenteritis

Overview of Gastroenteritis

  • gabriella
  • 53 Slides

Gastroenteritis is inflammation of the lining of t...

Hepatitis vaccines Hepatitis

Hepatitis vaccines Hepatitis

  • carla
  • 42 Slides

General term for Inflammatory condition of the . ...

Dr, Mohammed Arif Associate professor

Dr, Mohammed Arif Associate professor

  • reese
  • 46 Slides

Consultant virologist. Head of the virology unit. ...

Zoonotic disease Lecturer muna tawfeeq

Zoonotic disease Lecturer muna tawfeeq

  • erica
  • 22 Slides

Viral Hepatitis Infections. hepatitis is one of sy...

Hepatitis viruses Learning objectives

Hepatitis viruses Learning objectives

  • eloise
  • 31 Slides

: . Identify hepatitis viruses regarding their s...

Viral hepatitis The word

Viral hepatitis The word

  • miller
  • 11 Slides

. “. hepatitis”. . means. . inflammation. ....

Key Updates from 2023 Conference on Retroviruses and Opportunistic Infections (CROI)

Key Updates from 2023 Conference on Retroviruses and Opportunistic Infections (CROI)

  • josephine
  • 37 Slides

Jeffrey Lennox, MD. Professor of Medicine. Emory U...

Figure 1 Figure 1. Numbers of additional chronic hepatitis B cases after decreased coverage for hep

Figure 1 Figure 1. Numbers of additional chronic hepatitis B cases after decreased coverage for hep

  • leonard
  • 1 Slides

Kabore HJ, Li X, Allison RD, Avagyan T, Mihigo R, ...

Innovative Strategies for the Management

Innovative Strategies for the Management

  • karlyn-bohler
  • 37 Slides

of HIV Infection. Dual therapies without NRTIs. J...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 17 Slides

FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...

Update on risk factors, detection, and management of neuroc

Update on risk factors, detection, and management of neuroc

  • natalia-silvester
  • 61 Slides

Scott Letendre, M.D.. Professor of . Medicine and...

CDC’s Interim Guidance on the Use of PrEP in Heterosexual

CDC’s Interim Guidance on the Use of PrEP in Heterosexual

  • calandra-battersby
  • 81 Slides

Adults:. . Implications . for Clinical Practice....

COMING SOON:

COMING SOON:

  • luanne-stotts
  • 31 Slides

GENERIC ARVs. Tim Horn. Treatment Action Group. t...

TDF Microsoft Lync - Novembre 2010

TDF Microsoft Lync - Novembre 2010

  • faustina-dinatale
  • 9 Slides

Solutions & Architectures UC . Polycom. - Mi...

CROI 2015: HIV Prevention Updates

CROI 2015: HIV Prevention Updates

  • pamella-moone
  • 24 Slides

Ruanne V Barnabas, . MBChB. . Dphil. Global Heal...

Switch to ATV/

Switch to ATV/

  • cheryl-pisano
  • 16 Slides

r. + RAL. HARNESS Study. ATV/. r. 300/100 mg ....

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 6 Slides

FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...

Highlights of AIDS

Highlights of AIDS

  • calandra-battersby
  • 44 Slides

2016: Advances in . HIV Prevention, Care and Trea...

ID Week 2016: HIV Update

ID Week 2016: HIV Update

  • min-jolicoeur
  • 25 Slides

Robert Harrington, M.D.. ID Week 2016: HIV Update...

Comparison of INSTI vs INSTI

Comparison of INSTI vs INSTI

  • pamella-moone
  • 7 Slides

QDMRK. SPRING-2. ONCEMRK. ONCEMRK. Design. Object...

COMPARATIVE INVESTIGATIONS ON NUTRITIONAL COMPOSITIONS OF O

COMPARATIVE INVESTIGATIONS ON NUTRITIONAL COMPOSITIONS OF O

  • lois-ondreau
  • 55 Slides

GROWN CEREALS AND THEIR RELATIONSHIPS. Dr. . Mirj...

PrEP Training for

PrEP Training for

  • tatyana-admore
  • 124 Slides

Providers in Clinical Settings. 2. Welcome!. Plea...

Treatment-Experienced Patients in Resource-Limited Settings

Treatment-Experienced Patients in Resource-Limited Settings

  • pasty-toler
  • 12 Slides

Susan M. Graham . Assistant Professor, Medicine a...

Switch to PI/r + 3TC

Switch to PI/r + 3TC

  • lois-ondreau
  • 6 Slides

vs. PI/r . monotherapy. Study PIVOT. Study MOBID...

Les satisfactions : traitements efficaces, robustes, avec u

Les satisfactions : traitements efficaces, robustes, avec u

  • phoebe-click
  • 23 Slides

Dr Denis Lacoste. Bordeaux. Les satisfactions : ....

A Demonstration Open Label

A Demonstration Open Label

  • jane-oiler
  • 0 Slides

Study to Assess the . Acceptability. , Safety. a...

ART Resistance and Second Line Regimens

ART Resistance and Second Line Regimens

  • calandra-battersby
  • 0 Slides

Learning Objectives. Understand when to switch to...

Review of Non-Daily PrEP Clinical Research and Experience

Review of Non-Daily PrEP Clinical Research and Experience

  • mitsue-stanley
  • 0 Slides

Robert M. Grant, M.D., M.P.H. .. IAS 2017, July 2...

Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine

Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine

  • luanne-stotts
  • 0 Slides

Chief, Division of Infectious Diseases. Weill Med...

ART for Prevention… What Happens Next?

ART for Prevention… What Happens Next?

  • briana-ranney
  • 0 Slides

Myron S. Cohen, MD. Yeargan-Bate Eminent Professo...

Characteristics and Oral

Characteristics and Oral

  • lois-ondreau
  • 0 Slides

PrEP. Adherence in the TDF2 Open-Label Extension...

Adaptive non-inferiority

Adaptive non-inferiority

  • cheryl-pisano
  • 0 Slides

margins under observable non-constancy. Brett Han...

ART in Resource-limited settings :

ART in Resource-limited settings :

  • liane-varnes
  • 0 Slides

Progress and Challenges. Dr. B. B. . Rewari. MD,...

ADOLESCENT PrEP STUDIES

ADOLESCENT PrEP STUDIES

  • min-jolicoeur
  • 0 Slides

. . Shorai. . Mukaka. , . MBchB. ...

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

  • pamella-moone
  • 0 Slides

Guidelines for the Use of Antiretroviral Agents i...

Comprehensive Guideline Summary

Comprehensive Guideline Summary

  • aaron
  • 0 Slides

Guidelines for the Use of Antiretroviral Agents. ...

Second-Generation HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan

Second-Generation HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan

  • sherrill-nordquist
  • 0 Slides

± . Ritonavir. Carey Hwang. ,. 1. Dirk Schürma...

Duke Energy Carolinas ATC Calculation Process

Duke Energy Carolinas ATC Calculation Process

  • stefany-barnette
  • 0 Slides

ATC Training. December 15. th. , 2011. Agenda. Ob...

Copyright © 2024 DocSlides. All Rights Reserved